Delayed hemolytic transfusion reaction in the French hemovigilance system

被引：7
|
作者：
Rieux, C. [1 ]
Brittenham, G. [2 ]
Bachir, D. [3 ]
De Meyer, E. [1 ]
Boudjedir, K. [4 ]
机构：
[1] CHU Henri Mondor, Unite Hemovigilance & Securite Transfus, F-94010 Creteil, France
[2] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA
[3] CHU Henri Mondor, Ctr Reference Syndromes Drepanocytaires Majeurs, F-94010 Creteil, France
[4] Agence Natl Securite Medicament & Prod Sante ANSM, F-93285 St Denis, France
来源：
TRANSFUSION CLINIQUE ET BIOLOGIQUE | 2019年 / 26卷 / 02期
关键词：
Hemovigilance; Delayed hemolytic transfusion reactions; Sickle-cell disease;
D O I：
10.1016/j.tracli.2019.03.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In France, reporting of adverse events related, or likely to be related, to transfusion is mandatory. Since its creation in 1993, the French hemovigilance system has contributed to a better recognition of unappreciated risks like delayed hemolytic transfusion reactions (DHTR) in sickle-cell disease (SCD) patients. Long under-reported or misclassified, reports of this serious complication of transfusion have improved, particularly through the dissemination of information within the hemovigilance network. To our knowledge, the French hemovigilance system has one of the largest series of DHTR in SCD patients. Guidelines for diagnosis and reporting to hemovigilance system as well as a specific reporting form are being developed, which should contribute to the quality of data essential for epidemiological studies. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：109 / 111
页数：3
相关论文
共 50 条
  • [31] Hyperhemolytic Syndrome Complicating a Delayed Hemolytic Transfusion Reaction due to anti-P1 Alloimmunization, in a Pregnant Woman with HbO-Arab/β-Thalassemia
    Bezirgiannidou, Zoe
    Christoforidou, Anna
    Kontekaki, Eftychia
    Anastasiadis, Athanasios G.
    Papamichos, Spyros I.
    Menexidou, Helen
    Margaritis, Dimitrios
    Martinis, Georges
    Mantadakis, Elpis
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2016, 8
  • [32] Study of acute transfusion reactions in a teaching hospital of Sikkim: A hemovigilance initiative
    Sharma, Dhruva Kumar
    Datta, Supratim
    Gupta, Amlan
    INDIAN JOURNAL OF PHARMACOLOGY, 2015, 47 (04) : 370 - 374
  • [33] A lesson to learn from Hemovigilance: The impact of nurses' transfusion practice on mistransfusion
    Jimenez-Marco, T.
    Clemente-Marin, G.
    Girona-Llobera, E.
    Sedeno, M.
    Muncunill, J.
    TRANSFUSION AND APHERESIS SCIENCE, 2012, 47 (01) : 49 - 55
  • [34] Management of hemolytic transfusion reactions
    Hendrickson, Jeanne E.
    Fasano, Ross M.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 704 - 709
  • [35] Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report
    Beck, Tim N.
    Young, Natalee G.
    Erickson, Michelle L.
    Prats, Ignacio
    BMC SURGERY, 2017, 17
  • [36] Delayed haemolytic transfusion reaction: About 3 patients with sickle cell disease
    Bertrand, E.
    Dumesnil, C.
    Lahary, A.
    Al Bagami, M.
    Schneider, P.
    Levesque, H.
    Vannier, J. -P.
    REVUE DE MEDECINE INTERNE, 2015, 36 (11): : 769 - 772
  • [37] Cytokine changes in sickle-cell disease patients as markers predictive of the onset of delayed hemolytic transfusion reactions
    Chadebech, Philippe
    de Menorval, Marie-Amelie
    Bodivit, Gwellaouen
    Jouard, Alicia
    Pakdaman, Sadaf
    Lelong, Francoise
    Habibi, Anoosha
    Galacteros, Frederic
    Lecron, Jean Claude
    Pirenne, France
    CYTOKINE, 2020, 136
  • [38] Preventing antibody positive delayed hemolytic transfusion reactions in sickle cell disease: Lessons learned from a case
    Rankin, Alexander
    Webb, Jennifer
    Nickel, Robert Sheppard
    TRANSFUSION MEDICINE, 2022, 32 (05) : 433 - 436
  • [39] Postdonation information: The French fourth hemovigilance sub-process
    Py, J. -Y.
    Sandid, I.
    Jbilou, S.
    Dupuis, M.
    Adda, R.
    Narbey, D.
    Djoudi, R.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2014, 21 (4-5) : 216 - 222
  • [40] Epidemiological Data - an Important Part of the Hemovigilance System
    Offergeld, Ruth
    Hamouda, Osamah
    Burger, Reinhard
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2010, 37 (03) : 125 - 130
12345